Brainard Diana (CIK 0001818070)

Latest company ownership

Shares held
723,363
Last filed at
Nov 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 19, 2024 Nov 20, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -8,706 -1.19% ✗ $4.8K
Nov 5, 2024 Nov 6, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -10,609 -1.43% ✗ $9.2K
Oct 21, 2024 Oct 23, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -9,752 -1.30% ✗ $7.6K
Oct 3, 2024 Oct 4, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -1,493 -0.20% ✗ $1.2K
Aug 20, 2024 Aug 22, 2024 Kalaris Therapeutics, Inc. CEO Sell 50.0 -5,390 -0.71% ✗ $4K
Aug 19, 2024 Aug 20, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -3,091 -0.41% ✗ $2.3K
Aug 5, 2024 Aug 7, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -10,847 -1.40% ✗ $8K
Jul 19, 2024 Jul 23, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -9,731 -1.24% ✗ $7.3K
Jul 2, 2024 Jul 3, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -1,489 -0.19% ✗ $1.1K
May 21, 2024 May 23, 2024 Kalaris Therapeutics, Inc. CEO Sell 50.0 -5,149 -0.65% ✗ $4.1K
May 17, 2024 May 21, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -3,075 -0.39% ✗ $2.3K
May 3, 2024 May 7, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -10,240 -1.28% ✗ $8.2K
Apr 19, 2024 Apr 23, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -9,601 -1.18% ✗ $7.2K
Apr 2, 2024 Apr 4, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -1,533 -0.19% ✗ $1.2K
Feb 20, 2024 Feb 22, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -8,252 -1.00% ✗ $5.8K
Feb 5, 2024 Feb 6, 2024 Kalaris Therapeutics, Inc. CEO Sell 46.3 -41,421 -4.80% ✗ $27.8K
Jan 23, 2024 Jan 25, 2024 Kalaris Therapeutics, Inc. CEO Sell 47.5 -9,500 -1.09% ✗ $6.4K
Jan 4, 2024 Jan 8, 2024 Kalaris Therapeutics, Inc. CEO Sell 52.5 -1,664 -0.19% ✗ $1.1K
Nov 17, 2023 Nov 21, 2023 Kalaris Therapeutics, Inc. CEO Sell 48.8 -7,071 -0.80% ✗ $11.8K
Oct 19, 2023 Oct 23, 2023 Kalaris Therapeutics, Inc. CEO Sell 48.8 -8,581 -0.96% ✗ $13.6K
Oct 3, 2023 Oct 5, 2023 Kalaris Therapeutics, Inc. CEO Sell 52.5 -1,325 -0.15% ✗ $2.6K
Aug 17, 2023 Aug 21, 2023 Kalaris Therapeutics, Inc. CEO Sell 46.3 -15,416 -1.70% ✗ $39.7K
Jul 19, 2023 Jul 21, 2023 Kalaris Therapeutics, Inc. CEO Sell 48.8 -8,342 -0.91% ✗ $29.7K
Jul 5, 2023 Jul 6, 2023 Kalaris Therapeutics, Inc. CEO Sell 48.8 -5,275 -0.57% ✗ $16.1K
May 18, 2023 May 19, 2023 Kalaris Therapeutics, Inc. CEO Sell 51.3 -4,536 -0.49% ✗ $19.1K
Apr 19, 2023 Apr 21, 2023 Kalaris Therapeutics, Inc. CEO Sell 48.8 -8,408 -0.90% ✗ $31.2K
Feb 21, 2023 Feb 23, 2023 Kalaris Therapeutics, Inc. CEO Sell 51.3 -5,122 -0.55% ✓ $33.9K
Jan 19, 2023 Jan 23, 2023 Kalaris Therapeutics, Inc. CEO Sell 32.5 -34,435 -5.41% ✓ $174.9K
Nov 18, 2022 Nov 21, 2022 Kalaris Therapeutics, Inc. CEO Sell 51.3 -4,515 -0.71% ✓ $32.8K
Aug 18, 2022 Aug 19, 2022 Kalaris Therapeutics, Inc. CEO Sell 48.8 -4,564 -0.71% ✗ $35.4K
May 18, 2022 May 23, 2022 Kalaris Therapeutics, Inc. CEO Sell 42.5 -29,135 -5.59% ✗ $126.3K
Aug 3, 2020 Aug 5, 2020 Kalaris Therapeutics, Inc. Director Buy 95.0 +6,300 100.00% ✗ $107.1K